Company intelligence / Profile preview
Stem Cell Institute
Panama City, Panamacellmedicine.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
Over 55,000 procedures performed since 2006 using proprietary mesenchymal stem cell populations with published safety data, quality-controlled expansion, and international collaborations; primarily treats chronic degenerative and autoimmune conditions, with published observational/prospective results, but not marketed as a registrational trial sponsor.
- Therapeutic areas
- PsychiatryImmunologyGastroenterologyNeurologyPulmonologyEndocrinologyRheumatology
- Modalities
- Stem cell therapyCell therapyMesenchymal stem cell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Saint John’s Cancer InstitutePacific Neuroscience InstituteUniversity of Miami School of MedicineUniversity of Puerto Rico School of Public Health
Beyond the preview
Go deeper on Stem Cell Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stem Cell Institute.